Such a study would be small, and would look at the safety of the vaccine and the immune response to it. If one is required, though, Pfizer would have enough experimental vaccine to begin a clinical trial within about two months, Dolsten said. What’s known and unknown about Omicron, the coronavirus variant identified in South Africa Exclusive analysis of biotech, pharma, and the life sciences Learn More
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |